Humane Genomics
YC S21New York City, US · Founded 2019 · 5 employees · 7 known investors
Find your way into Humane Genomics
435 people in our graph share verified history with the Humane Genomics team — schools, employers, funds. One of them is your warm intro.
Humane Genomics develops oncolytic viral therapies designed to selectively target and kill cancer cells using engineered RNA viruses, particularly Vesicular Stomatitis Virus. The company leverages a computational platform for viral genome design and engineering to create cancer treatments with improved safety, efficacy, and manufacturing efficiency.
Founders & leadership· Y Combinator alumni (S21)
Humane Genomics was founded in 2019 by Peter Weijmarshausen and Chad Moles.


Investors · 7
Funding
SEC filings, press & company announcements- Undisclosed amountSeedFeb 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 2
by search overlapCompanies competing with Humane Genomics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Humane Genomics do?
- Humane Genomics develops oncolytic viral therapies designed to selectively target and kill cancer cells using engineered RNA viruses, particularly Vesicular Stomatitis Virus. The company leverages a computational platform for viral genome design and engineering to create cancer treatments with improved safety, efficacy, and manufacturing efficiency.
- Who founded Humane Genomics?
- Humane Genomics was founded by Peter Weijmarshausen, Chad Moles in 2019.
- Who are Humane Genomics's investors?
- Humane Genomics's investors include 2048 Ventures, Humba Ventures, Leo Capital Ventures, LifeX Ventures, Red Beard Ventures, Union Square Ventures (USV), Y Combinator.
- Where is Humane Genomics headquartered?
- Humane Genomics is headquartered in New York City, US.



.jpeg)




